- Home
- PLSE vs DGII Comparison
PLSE vs DGII Comparison
Compare PLSE & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- DGII
- Stock Information
- Founded
- PLSE 2014
- DGII 1985
- Country
- PLSE United States
- DGII United States
- Employees
- PLSE N/A
- DGII N/A
- Industry
- PLSE Medical/Dental Instruments
- DGII Computer peripheral equipment
- Sector
- PLSE Health Care
- DGII Technology
- Exchange
- PLSE Nasdaq
- DGII Nasdaq
- Market Cap
- PLSE 1.1B
- DGII 1.1B
- IPO Year
- PLSE 2016
- DGII N/A
- Fundamental
- Price
- PLSE $17.82
- DGII $32.99
- Analyst Decision
- PLSE
- DGII Buy
- Analyst Count
- PLSE 0
- DGII 5
- Target Price
- PLSE N/A
- DGII $34.80
- AVG Volume (30 Days)
- PLSE 129.7K
- DGII 178.3K
- Earning Date
- PLSE 10-30-2024
- DGII 02-05-2025
- Dividend Yield
- PLSE N/A
- DGII N/A
- EPS Growth
- PLSE N/A
- DGII N/A
- EPS
- PLSE N/A
- DGII 0.61
- Revenue
- PLSE N/A
- DGII $424,046,000.00
- Revenue This Year
- PLSE N/A
- DGII $2.01
- Revenue Next Year
- PLSE N/A
- DGII $5.11
- P/E Ratio
- PLSE N/A
- DGII $54.02
- Revenue Growth
- PLSE N/A
- DGII N/A
- 52 Week Low
- PLSE $6.60
- DGII $20.17
- 52 Week High
- PLSE $22.69
- DGII $34.82
- Technical
- Relative Strength Index (RSI)
- PLSE 47.74
- DGII 65.27
- Support Level
- PLSE $17.18
- DGII $29.85
- Resistance Level
- PLSE $19.90
- DGII $30.39
- Average True Range (ATR)
- PLSE 1.07
- DGII 1.00
- MACD
- PLSE 0.01
- DGII 0.45
- Stochastic Oscillator
- PLSE 22.44
- DGII 95.48
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
About DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.